Anatomical and cellular requirements for the activation and migration of virus-specific CD8+ T cells to the brain during Theiler's virus infection.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 548433)

Published in J Virol on March 01, 2005

Authors

Yanice V Mendez-Fernandez1, Michael J Hansen, Moses Rodriguez, Larry R Pease

Author Affiliations

1: Department of Immunology, Mayo Clinic College of Medicine, 200 First Ave. SW, Rochester, MN 55905, USA.

Articles cited by this

Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun (1975) 7.12

Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science (1994) 7.10

Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity (2003) 5.52

HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc Natl Acad Sci U S A (1992) 5.02

The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol (1995) 2.57

Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur J Immunol (1987) 2.41

CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A (1996) 2.38

Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance. Brain Pathol (1992) 2.22

Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J Neuropathol Exp Neurol (1992) 2.19

Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system. J Immunol (1999) 2.19

Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J Exp Med (1986) 2.18

Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity. J Immunol (1985) 2.06

Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J Immunol (1985) 1.98

Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today (1992) 1.96

Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol Today (2000) 1.77

Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J Virol (1999) 1.68

Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. Crit Rev Immunol (1987) 1.65

Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J Immunol (2002) 1.54

Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. J Immunol (2001) 1.53

Microglia are the major cell type expressing MHC class II in human white matter. J Neurol Sci (1987) 1.50

Initiation of immune responses in brain is promoted by local dendritic cells. J Immunol (2004) 1.48

FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler's virus. J Virol (1994) 1.48

Drainage of cerebral interstitial fluid into deep cervical lymph of the rabbit. Am J Physiol (1981) 1.41

Brain macrophages: on the role of pericytes and perivascular cells. Brain Res Brain Res Rev (1999) 1.39

Kinetics of virus-specific CD8+ -T-cell expansion and trafficking following central nervous system infection. J Virol (2003) 1.37

Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice. J Virol (1997) 1.36

Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus. J Virol (2001) 1.34

Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J Immunol (1998) 1.32

Impaired T cell immunity in B cell-deficient mice following viral central nervous system infection. J Immunol (2001) 1.31

Lymphotoxin-alpha-deficient mice make delayed, but effective, T and B cell responses to influenza. J Immunol (2002) 1.29

Clearance of Theiler's virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide. Eur J Immunol (2003) 1.25

Role of cervical lymph nodes in the systemic humoral immune response to human serum albumin microinfused into rat cerebrospinal fluid. J Neuroimmunol (1989) 1.24

Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol (1998) 1.22

Brain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J Virol (1997) 1.14

Immunoglobulins stimulate central nervous system remyelination: electron microscopic and morphometric analysis of proliferating cells. Lab Invest (1991) 1.10

Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain. J Virol (1993) 1.09

Major histocompatibility complex-conferred resistance to Theiler's virus-induced demyelinating disease is inherited as a dominant trait in B10 congenic mice. J Virol (1990) 1.08

The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neuropathol Exp Neurol (1995) 1.06

Differential expression of H-2K and H-2D in the central nervous system of mice infected with Theiler's virus. J Immunol (1993) 1.04

H-2D(b-/-) mice are susceptible to persistent infection by Theiler's virus. J Virol (2000) 1.03

Immunological ignorance of an E7-encoded cytolytic T-lymphocyte epitope in transgenic mice expressing the E7 and E6 oncogenes of human papillomavirus type 16. J Virol (1997) 1.01

Lymphotoxin alpha-/- mice develop functionally impaired CD8+ T cell responses and fail to contain virus infection of the central nervous system. J Immunol (2001) 1.01

Role of lymphotoxin alpha in T-cell responses during an acute viral infection. J Virol (2002) 0.99

Roles of the H-2D(b) and H-K(b) genes in resistance to persistent Theiler's murine encephalomyelitis virus infection of the central nervous system. J Gen Virol (2001) 0.99

Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions. Immunology (1992) 0.95

Characterization of and functional antigen presentation by central nervous system mononuclear cells from mice infected with Theiler's murine encephalomyelitis virus. J Virol (1998) 0.93

Role of cervical lymph nodes in autoimmune encephalomyelitis in the Lewis rat. J Pathol (1997) 0.91

Astrocytes protect the CNS: antigen-specific T helper cell responses are inhibited by astrocyte-induced upregulation of CTLA-4 (CD152). J Mol Med (Berl) (2004) 0.90

T lymphocyte repertoire in Theiler's virus encephalomyelitis: the nonspecific infiltration of the central nervous system of infected SJL/J mice is associated with a selective local T cell expansion. Eur J Immunol (1995) 0.90

Clonal expansion of infiltrating T cells in the spinal cords of SJL/J mice infected with Theiler's virus. J Immunol (2000) 0.88

In situ inactivation of infiltrating T cells in the central nervous system with autoimmune encephalomyelitis. The role of astrocytes. Immunology (1993) 0.86

Microglial cells qualify as the stimulators of unprimed CD4+ and CD8+ T lymphocytes in the central nervous system. Clin Exp Immunol (1994) 0.84

Induction of primary T cell responses by human glial cells. J Neurosci Res (1993) 0.83

Membrane lymphotoxin is required for resistance to Theiler's virus infection. Int Immunol (2003) 0.83

Recruitment, activation and proliferation of CD8+ memory T cells in an immunoprivileged site. Eur J Immunol (1997) 0.81

Human microglia activate lymphoproliferative responses to recall viral antigens. J Neuroimmunol (1996) 0.81

HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro. Immunology (1994) 0.80

Theiler's virus-infected L-selectin-deficient mice have decreased infiltration of CD8(+) T lymphocytes in central nervous system but clear the virus. J Neuroimmunol (2001) 0.78

Granulocyte-macrophage colony stimulating factor inhibits class II major histocompatibility complex expression and antigen presentation by microglia. J Neuroimmunol (1993) 0.77

Specialisation of thymic epithelial cells for positive selection of CD4+8+ thymocytes. Cell Mol Biol (Noisy-le-grand) (2001) 0.77

Articles by these authors

Gene splicing and mutagenesis by PCR-driven overlap extension. Nat Protoc (2007) 6.11

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet (2005) 2.68

Not every patient with multiple sclerosis should be treated at time of diagnosis. Arch Neurol (2006) 2.67

Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study. Arch Neurol (2004) 2.37

Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. J Clin Invest (2002) 2.21

Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys (2006) 2.12

Semaphorin 5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans. Neuron (2004) 2.10

Retracted Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo. J Immunol (2008) 1.69

Retracted Cross-linking the B7 family molecule B7-DC directly activates immune functions of dendritic cells. J Exp Med (2002) 1.68

Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis. Arch Neurol (2010) 1.61

Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneous breast tumors. Cancer Res (2007) 1.49

Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch Neurol (2011) 1.49

Retracted CTL activation using the natural low-affinity epitope 222-229 from tyrosinase-related protein 1 leads to tumor rejection. Cancer Res (2009) 1.41

The relevance of animal models in multiple sclerosis research. Pathophysiology (2011) 1.40

Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol (2004) 1.36

Absence of perforin expression confers axonal protection despite demyelination. Neurobiol Dis (2006) 1.26

Retracted Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunity. Cancer Res (2004) 1.26

Asthma-related environmental fungus, Alternaria, activates dendritic cells and produces potent Th2 adjuvant activity. J Immunol (2009) 1.26

Clearance of Theiler's virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide. Eur J Immunol (2003) 1.25

Odorant emissions from intensive pig production measured by online proton-transfer-reaction mass spectrometry. Environ Sci Technol (2010) 1.22

Lineage(-)Sca1+c-Kit(-)CD25+ cells are IL-33-responsive type 2 innate cells in the mouse bone marrow. J Immunol (2011) 1.22

Retracted Naturally occurring human IgM antibody that binds B7-DC and potentiates T cell stimulation by dendritic cells. J Immunol (2003) 1.21

Surface plasmon resonance for high-throughput ligand screening of membrane-bound proteins. Biotechnol J (2009) 1.15

Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. BioTechniques 8(5):528-535 (November 1990). Biotechniques (2013) 1.15

A recombinant human IgM promotes myelin repair after a single, very low dose. J Neurosci Res (2007) 1.15

Interleukin-6 protects anterior horn neurons from lethal virus-induced injury. J Neurosci (2003) 1.15

Retracted Dendritic cells activated by cross-linking B7-DC (PD-L2) block inflammatory airway disease. J Allergy Clin Immunol (2005) 1.15

Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management. CNS Drugs (2009) 1.14

Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair. Mol Cell Neurosci (2003) 1.14

CD8+ T cells directed against a viral peptide contribute to loss of motor function by disrupting axonal transport in a viral model of fulminant demyelination. J Neuroimmunol (2007) 1.12

Efficient central nervous system remyelination requires T cells. Ann Neurol (2003) 1.11

Antigen-specific CD8+ T cells mediate a peptide-induced fatal syndrome. J Immunol (2005) 1.09

Retracted Blockade of allergic airway inflammation following systemic treatment with a B7-dendritic cell (PD-L2) cross-linking human antibody. J Immunol (2004) 1.09

A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS. FASEB J (2004) 1.08

Neuron-binding human monoclonal antibodies support central nervous system neurite extension. J Neuropathol Exp Neurol (2004) 1.08

Retracted B7-DC cross-linking restores antigen uptake and augments antigen-presenting cell function by matured dendritic cells. Proc Natl Acad Sci U S A (2005) 1.07

Acute hemorrhagic demyelination in a murine model of multiple sclerosis. J Neuroinflammation (2008) 1.07

Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease. J Clin Invest (2002) 1.07

Demyelinated axons and motor function are protected by genetic deletion of perforin in a mouse model of multiple sclerosis. J Neuropathol Exp Neurol (2009) 1.06

Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice. Glia (2002) 1.06

Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration. Biol Chem (2008) 1.06

HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice. J Neuroimmunol (2005) 1.04

Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network. J Child Neurol (2012) 1.04

Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic mice. Eur J Immunol (2004) 1.04

Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease. FASEB J (2002) 1.04

Disrupted spatial memory is a consequence of picornavirus infection. Neurobiol Dis (2006) 1.04

Enzymatic properties of rat myelencephalon-specific protease. Biochemistry (2002) 1.03

Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Mult Scler (2012) 1.01

Later-onset Fabry disease: an adult variant presenting with the cramp-fasciculation syndrome. Arch Neurol (2006) 1.01

Targeting kallikrein 6 proteolysis attenuates CNS inflammatory disease. FASEB J (2004) 1.01

CD8+ T cells cause disability and axon loss in a mouse model of multiple sclerosis. PLoS One (2010) 0.99

Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population. Mov Disord (2004) 0.99

Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody. Neurobiol Dis (2004) 0.99

PCR Mutagenesis by Overlap Extension and Gene SOE. CSH Protoc (2008) 0.98

Brainstem 1H nuclear magnetic resonance (NMR) spectroscopy: marker of demyelination and repair in spinal cord. Ann Neurol (2009) 0.98

Magnetic resonance imaging, microscopy, and spectroscopy of the central nervous system in experimental animals. NeuroRx (2005) 0.97

Facile assembly of micro- and nanoarrays for sensing with natural cell membranes. ACS Nano (2011) 0.95

HLA-DQ6 (DQB1*0601)-restricted T cells protect against experimental autoimmune encephalomyelitis in HLA-DR3.DQ6 double-transgenic mice by generating anti-inflammatory IFN-gamma. J Immunol (2008) 0.95

Genetically dominant spinal cord repair in a murine model of chronic progressive multiple sclerosis. J Neuropathol Exp Neurol (2005) 0.94

MRI in rodent models of brain disorders. Neurotherapeutics (2011) 0.94

A single dose of neuron-binding human monoclonal antibody improves spontaneous activity in a murine model of demyelination. PLoS One (2011) 0.94

Is multiple sclerosis an autoimmune disease? Autoimmune Dis (2012) 0.94

Invited article: human natural autoantibodies in the treatment of neurologic disease. Neurology (2009) 0.93

Pediatric multiple sclerosis. Neurol Clin (2011) 0.93

Retracted Induction of a Th1 response from Th2-polarized T cells by activated dendritic cells: dependence on TCR:peptide-MHC interaction, ICAM-1, IL-12, and IFN-gamma. J Immunol (2007) 0.93

Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus. Brain Pathol (2003) 0.92

Transgenic expression of Theiler's murine encephalomyelitis virus genes in H-2(b) mice inhibits resistance to virus-induced demyelination. J Virol (2002) 0.91

Retracted B7-DC/PD-L2 cross-linking induces NF-kappaB-dependent protection of dendritic cells from cell death. J Immunol (2007) 0.91

Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy. PLoS One (2011) 0.90

Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice. J Autoimmun (2012) 0.90

Genetic deletion of a single immunodominant T-cell response confers susceptibility to virus-induced demyelination. Brain Pathol (2007) 0.90

Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues. Ann N Y Acad Sci (2009) 0.90

A function of myelin is to protect axons from subsequent injury: implications for deficits in multiple sclerosis. Brain (2003) 0.89

Polyreactive antibodies to glatiramer acetate promote myelin repair in murine model of demyelinating disease. FASEB J (2002) 0.88

Fast-tracked CTL: rapid induction of potent anti-tumor killer T cells in situ. Eur J Immunol (2007) 0.88

Retracted Induction of a gene expression program in dendritic cells with a cross-linking IgM antibody to the co-stimulatory molecule B7-DC. FASEB J (2006) 0.88

Retracted An effective vaccine strategy protective against antigenically distinct tumor variants. Cancer Res (2008) 0.88